These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 4328031

  • 21. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 22. Treatment of the nephrotic syndrome.
    Br Med J; 1970 Jul 11; 3(5714):58-9. PubMed ID: 4316980
    [No Abstract] [Full Text] [Related]

  • 23. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ, Wetzels JF.
    Ned Tijdschr Geneeskd; 1998 Dec 26; 142(52):2832-8. PubMed ID: 10065257
    [Abstract] [Full Text] [Related]

  • 24. [Nephrotic syndrome in childhood].
    Reusz G, Szabó A, Fekete A.
    Orv Hetil; 2006 Nov 26; 147(47):2251-60. PubMed ID: 17380687
    [Abstract] [Full Text] [Related]

  • 25. [Nephrotic syndrome. Official report of the Section of Pediatric Nephrology].
    García García L, Martín Govantes J, Navarro Torres M, Simón González J, Vallo Boada A.
    An Esp Pediatr; 1982 Oct 26; 17(4):354-8. PubMed ID: 7158884
    [No Abstract] [Full Text] [Related]

  • 26. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G, Bariety J.
    Minerva Med; 1970 Jul 11; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract] [Full Text] [Related]

  • 27. [Therapy of diffuse pulmonary fibrosis (including prevention of development and progression)].
    Dierkesmann R, Cegla UH, Meier-Sydow J, Kroidl R.
    Internist (Berl); 1974 Jul 11; 15(7):386-90. PubMed ID: 4608973
    [No Abstract] [Full Text] [Related]

  • 28. Factors predictive of remission in steroid resistant nephrotic syndrome in children: a multivariate analysis.
    Gulati S, Saha A.
    Indian Pediatr; 2007 May 11; 44(5):395-6. PubMed ID: 17536147
    [No Abstract] [Full Text] [Related]

  • 29. [Results of immunosuppressive treatment of nephrotic syndrome].
    Przybyl L, Salwa-Kubasik W, Urbański K, Wróz M, Hryniewiecki J.
    Pol Tyg Lek; 1973 Jun 25; 28(26):990-3. PubMed ID: 4727614
    [No Abstract] [Full Text] [Related]

  • 30. Hormonal treatment of lipoid nephrosis.
    MAGGI R, CAPURRO JD, VECCHIO H, MATERA FC, GIANANTONIO CA.
    Dia Med; 1958 Mar 27; 30(16):490 passim. PubMed ID: 13537809
    [No Abstract] [Full Text] [Related]

  • 31. [The combination of indomethacin and prednisone in the treatment of primary nephrotic syndrome in children].
    Creţu S, Mustafa E, Mustafa G.
    Rev Pediatr Obstet Ginecol Pediatr; 1980 Mar 27; 29(3):269-75. PubMed ID: 6781036
    [No Abstract] [Full Text] [Related]

  • 32. [Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents)].
    Lagrue G, Bariéty J.
    Munch Med Wochenschr; 1970 Mar 20; 112(12):515-22. PubMed ID: 5467836
    [No Abstract] [Full Text] [Related]

  • 33. [Experience with treating the nephrotic syndrome caused by glomerulonephritis].
    Ratner NA, Abugova SP, Kozdoba OA, Paleeva FM, Pliutto IA.
    Ter Arkh; 1973 May 20; 45(5):82-90. PubMed ID: 4768380
    [No Abstract] [Full Text] [Related]

  • 34. [Idiopathic nephrotic syndrome with minimal glomerular lesions or with diffuse mesangial proliferation. Comparison of 2 groups of children].
    Giani M, Ripanti G, Stucchi C, Bettinelli A, Bertoletti A, Claris Appiani A, Ghio L, Gaboardi F, Edefonti A.
    Minerva Nefrol; 1980 May 20; 27(4):539-42. PubMed ID: 7254677
    [No Abstract] [Full Text] [Related]

  • 35. [Nephrotic syndrome].
    Yokoyama H, Wada T.
    Ryoikibetsu Shokogun Shirizu; 2000 May 20; (32):484-6. PubMed ID: 11212781
    [No Abstract] [Full Text] [Related]

  • 36. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N, Quartuccio L, De Marchi G, De Vita S.
    Reumatismo; 2007 May 20; 59(3):202-8. PubMed ID: 17898879
    [Abstract] [Full Text] [Related]

  • 37. Editorial: Immunosuppression in nephrotics--praises and restraints.
    Chugh KS.
    J Assoc Physicians India; 1973 Jan 20; 21(1):77-9. PubMed ID: 4792705
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative evaluation of the treatment of pemphigus with corticosteroids and corticosteroids combined with immunosuppressive agents].
    Michałowski R, Kuczyńska L.
    Przegl Dermatol; 1981 Jan 20; 68(2):227-32. PubMed ID: 7029660
    [No Abstract] [Full Text] [Related]

  • 39. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Jan 20; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of steroid-resistant idiopathic nephrotic syndrome].
    Chemli J, Harbi A.
    Arch Pediatr; 2009 Mar 20; 16(3):260-8. PubMed ID: 19195856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.